Sabine Mai

Net worth: 233 266 $ as of 2024-03-30

Health Services

Consumer Services

Profile

Sabine Mai is the founder of Telo Genomics Corp.
which was founded in 2011.
She holds the title of Director at Telo Genomics Corp.
Dr. Mai's current jobs include being a Director at The Genomic Centre For Cancer Research & Diagnosis and a Professor at the University of Manitoba.
Dr. Mai's former job was being a Director at 3D Signatures, Inc.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
TELO GENOMICS CORP. 3.95%	2023-12-07	2,810,433 ( 3.95% )	233 266 $	2024-03-30

Sabine Mai active positions

Companies	Position	Start
TELO GENOMICS CORP.	Founder	2011-05-24
University of Manitoba	Corporate Officer/Principal	-
The Genomic Centre For Cancer Research & Diagnosis	Director/Board Member	-

All active positions of Sabine Mai

Former positions of Sabine Mai

Companies	Position	End
3D Signatures, Inc. /Old/ 3D Signatures, Inc. /Old/ Medical/Nursing ServicesHealth Services 3D Signatures, Inc. develops diagnostic and prognostic products. It provides diagnostic and prognostic tools for cancer and Alzheimer's disease. 3D Signatures is in the process of developing 3D Telo-PC for prostate cancer and 3D Telo-RS for Hodgkin’s Lymphoma. The company is headquartered in Winnipeg, Canada.	Director/Board Member	-

See the detail of Sabine Mai's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sabine Mai's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
TELO GENOMICS CORP.	Health Services

Private companies	2
3D Signatures, Inc. /Old/ 3D Signatures, Inc. /Old/ Medical/Nursing ServicesHealth Services 3D Signatures, Inc. develops diagnostic and prognostic products. It provides diagnostic and prognostic tools for cancer and Alzheimer's disease. 3D Signatures is in the process of developing 3D Telo-PC for prostate cancer and 3D Telo-RS for Hodgkin’s Lymphoma. The company is headquartered in Winnipeg, Canada.	Health Services
The Genomic Centre For Cancer Research & Diagnosis